Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Syntara.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight
News
CLOSING BELL: A crazy ride for tech stocks and Wildcat as the ASX dips 0.22%
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
MoneyTalks: Brokers see blue sky for these 3 ASX biotech stocks, with massive price targets
Health & Biotech
ASX Health Stocks: Pharmaxis and Aroa lift on FDA news, Cynata to commence Phase 2 trial
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall, Healius receives $1.52 billion takeover offer
News
Trading Places: Rinehart makes play for Warrego Energy, Whitehaven gets new substantial shareholder
Health & Biotech
ScoPo’s Powerplays: ASX health stocks rattling the tin, Telix shares soar ~26% on positive quarterly results
Health & Biotech
Clinical Trials 101: How to spot a clinical trial with a strong chance of getting a drug to market
Health & Biotech
ASX Health Stocks: Botanix seeks nod from US FDA; PainChek goes big in Japan
Experts
CRITERION: The ASX small caps that are trading for less than they’re actually worth
Health & Biotech
This ASX stock is watching you while you sleep… because it could point to Parkinson’s disease
Experts
ScoPo’s Powerplays: ASX health stocks finish reporting season in pretty strong shape
Health & Biotech
ASX Health Stocks: Pharmaxis gets $5m to fund groundbreaking collaboration study of lead drug PXS‐4728
News
Market Highlights: Euro inflation hits record high and 5 ASX small caps to watch on Thursday
Health & Biotech
Here are the Top 10 crucial trials coming up for ASX biotechs in 2022
Experts
